Can-Fite BioPharma Ltd. (CANF)
1.90
-0.10
(-5.00%)
USD |
NYAM |
Oct 09, 16:00
1.91
+0.01
(+0.53%)
After-Hours: 20:00
Can-Fite BioPharma Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.652M |
| September 30, 2023 | -1.762M |
| June 30, 2023 | -1.67M |
| March 31, 2023 | -2.55M |
| December 31, 2022 | -3.019M |
| September 30, 2022 | -2.529M |
| June 30, 2022 | -2.191M |
| March 31, 2022 | -2.434M |
| December 31, 2021 | -4.118M |
| September 30, 2021 | -3.40M |
| June 30, 2021 | -3.219M |
| March 31, 2021 | -1.878M |
| December 31, 2020 | -3.633M |
| September 30, 2020 | -2.575M |
| June 30, 2020 | -3.893M |
| March 31, 2020 | -4.342M |
| December 31, 2019 | -1.746M |
| September 30, 2019 | -2.948M |
| June 30, 2019 | -3.061M |
| March 31, 2019 | -1.832M |
| December 31, 2018 | -3.429M |
| September 30, 2018 | -0.177M |
| June 30, 2018 | -1.244M |
| March 31, 2018 | -1.721M |
| December 31, 2017 | -1.720M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.206M |
| June 30, 2017 | -1.796M |
| March 31, 2017 | -1.762M |
| December 31, 2016 | -1.944M |
| September 30, 2016 | -2.158M |
| June 30, 2016 | -1.458M |
| March 31, 2016 | -1.481M |
| December 31, 2015 | 0.1952M |
| September 30, 2015 | -3.186M |
| June 30, 2015 | -1.747M |
| March 31, 2015 | -0.3815M |
| December 31, 2014 | -1.994M |
| September 30, 2014 | -1.289M |
| June 30, 2014 | -1.760M |
| March 31, 2014 | -1.790M |
| December 31, 2013 | -3.187M |
| September 30, 2013 | -1.477M |
| June 30, 2013 | -1.754M |
| March 31, 2013 | -2.137M |
| December 31, 2012 | -1.743M |
| September 30, 2012 | -1.211M |
| June 30, 2012 | -1.251M |
| March 31, 2012 | -1.495M |
| December 31, 2011 | -3.464M |
| September 30, 2011 | -0.946M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioLineRx Ltd. | -4.414M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 9.262M |
| Eocene Ltd. | -2.723M |
| Revium Recovery, Inc. | -0.584M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | -4.811M |
| Earnings Yield | -331.5% |
| Normalized Earnings Yield | -331.45 |